Physician

Robert J Karl, M.D.

According to 2025 Medicare claims, Robert Karl, M.D. (NPI: 1073595435) practices family practice in the Spartanburg, SC market, with the plurality of this provider's patient population coming from Spartanburg, SC. This provider's primary affiliated billing organization is FAMILY PHYSICIANS OF SPARTANBURG, PC (NPI: 1629228382; TIN: 26-2597357) and primary practice location at 29301-5643. Karl is affiliated with the Aledade 153 SC MSSP Enhanced (ACO ID: A5356), participating under the MSSP model.

Karl's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 347 traditional Medicare patients, billed 13,673 HCPCS/CPT codes, and received $330,805 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 8,620 prescription claims across 505 beneficiaries totaling $829,963 in drug costs, led by Ozempic (Semaglutide). DME data shows 238 claims. Open Payments data shows 51 records totaling $875. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $353,497 to $330,805. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $648,512 and ending at $829,963. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $17,046 to $30,584.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	416	14,816	$353,497
2016	460	17,771	$405,546
2017	483	21,227	$507,383
2018	509	22,818	$523,668
2019	532	24,062	$520,784
2020	532	24,201	$506,410
2021	553	22,760	$525,650
2022	498	12,309	$264,406
2023	230	3,060	$97,806
2024	347	13,673	$330,805

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	633	9,321	$648,512
2016	561	12,185	$862,462
2017	646	13,055	$1,023,180
2018	705	12,425	$1,090,110
2019	738	13,018	$1,207,048
2020	746	13,290	$1,296,692
2021	775	12,760	$1,320,060
2022	746	10,382	$1,127,877
2023	549	1,911	$192,703
2024	505	8,620	$829,963

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	91	346	$11,208
2016	132	341	$8,846
2017	100	377	$9,120
2018	197	538	$12,354
2019	182	530	$13,189
2020	177	441	$14,489
2021	222	639	$29,434
2022	208	649	$39,496
2023	75	313	$25,222
2024	49	238	$27,374

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	289	980	$79
80053	Blood test, comprehensive group of blood chemicals	272	674	$10
36415	Insertion of needle into vein for collection of blood sample	284	797	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	279	697	$8
81000	Manual urinalysis test with examination using microscope, non-automated	267	519	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	112	4,358	$128,575
Eliquis	Apixaban	106	3,943	$73,210
Farxiga	Dapagliflozin Propanediol	37	2,610	$47,752
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	2,310	$47,583
Repatha Sureclick	Evolocumab	41	2,052	$38,859

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	12	57	$21,635
A7031	Face mask interface, replacement for full face mask, each	N	N/R	18	$1,382
A7030	Full face mask used with positive airway pressure device, each	N	N/R	16	$1,198
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	29	$1,156
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	11	20	$603

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	51	$875	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert J. Karl, M.D.?

Tedicare shows public-source Medicare data for Robert J. Karl, M.D. (NPI 1073595435), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert J. Karl, M.D. have ACO affiliation data?

Robert J. Karl, M.D. is shown with ACO affiliation data for Aledade 153 SC MSSP Enhanced (MSSP, ACO ID A5356).

What billing organization is linked to Robert J. Karl, M.D.?

Robert J. Karl, M.D. is linked to FAMILY PHYSICIANS OF SPARTANBURG, PC (billing NPI 1629228382) in the available physician profile data.

Does Robert J. Karl, M.D. have Open Payments data?

Robert J. Karl, M.D. has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.